0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Allergiya i desensibilizatsiya

JAMA. 1940;115(24):2108. doi:10.1001/jama.1940.02810500076038.
Text Size: A A A
Published online

ABSTRACT

This small volume, published by the Ukrainian Institute of Experimental Medicine, contains brief reports on experimental and clinical studies in allergy and desensitization by Prof. D. E. Alpern and his co-workers. Alpern makes a distinction between specific and nonspecific desensitization. The first consists in creating within the organism a resistance to the antigen by immunobiologic action in the presence of antibodies. By nonspecific desensitization is meant the reduction of the exaggerated reactivity by means other than immunobiologic, namely, through the intervention of the regulatory systems of the organism, its metabolism and so on. There are chapters dealing with animal experiments and clinical trial of histamine, of ultrashort waves and of intermedin. Alpern claims to have obtained this hormone containing extract of the pars intermedia of the hypophysis long before Zondek (1932) described intermedin containing the melanoforming hormone. He describes his method of obtaining the hormone from the hypophysis of small

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();